share_log

We Think You Should Be Aware Of Some Concerning Factors In Eastman Chemical's (NYSE:EMN) Earnings

We Think You Should Be Aware Of Some Concerning Factors In Eastman Chemical's (NYSE:EMN) Earnings

我們認爲您應該了解伊士曼化學(紐約證券交易所代碼:EMN)收益中的一些令人擔憂的因素
Simply Wall St ·  02/14 08:24

Eastman Chemical Company's (NYSE:EMN) robust recent earnings didn't do much to move the stock. However the statutory profit number doesn't tell the whole story, and we have found some factors which might be of concern to shareholders.

伊士曼化學公司(紐約證券交易所代碼:EMN)近期的強勁收益並沒有對該股產生太大影響。但是,法定利潤數字並不能說明全部情況,我們發現了一些可能引起股東關注的因素。

earnings-and-revenue-history
NYSE:EMN Earnings and Revenue History February 14th 2024
紐約證券交易所:EMN 收益和收入歷史記錄 2024 年 2 月 14 日

The Impact Of Unusual Items On Profit

不尋常物品對利潤的影響

To properly understand Eastman Chemical's profit results, we need to consider the US$271m gain attributed to unusual items. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. And, after all, that's exactly what the accounting terminology implies. If Eastman Chemical doesn't see that contribution repeat, then all else being equal we'd expect its profit to drop over the current year.

爲了正確了解伊士曼化工的利潤業績,我們需要考慮不尋常項目帶來的2.71億美元收益。雖然獲得更高的利潤總是件好事,但來自不尋常物品的巨額捐款有時會抑制我們的熱情。我們統計了全球大多數上市公司的數字,不尋常的物品在自然界中很常見。而且,畢竟,這正是會計術語的含義。如果伊士曼化學認爲這一貢獻不會重演,那麼在其他條件相同的情況下,我們預計其本年度的利潤將下降。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。

Our Take On Eastman Chemical's Profit Performance

我們對伊士曼化學利潤表現的看法

Arguably, Eastman Chemical's statutory earnings have been distorted by unusual items boosting profit. Therefore, it seems possible to us that Eastman Chemical's true underlying earnings power is actually less than its statutory profit. But the good news is that its EPS growth over the last three years has been very impressive. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you'd like to know more about Eastman Chemical as a business, it's important to be aware of any risks it's facing. You'd be interested to know, that we found 2 warning signs for Eastman Chemical and you'll want to know about them.

可以說,伊士曼化工的法定收益被提高利潤的不尋常項目所扭曲。因此,在我們看來,伊士曼化學的真正潛在盈利能力實際上可能低於其法定利潤。但好消息是,其在過去三年中的每股收益增長非常令人印象深刻。本文的目標是評估我們在多大程度上可以依靠法定收益來反映公司的潛力,但還有很多需要考慮的地方。如果您想進一步了解伊士曼化學作爲一家企業,請務必了解其面臨的任何風險。你可能會有興趣知道,我們發現了兩個伊士曼化學的警告標誌,你會想知道的。

This note has only looked at a single factor that sheds light on the nature of Eastman Chemical's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

這份報告只研究了揭示伊士曼化學利潤性質的單一因素。但是,如果你能夠將注意力集中在細節上,總會有更多的事情需要發現。有些人認爲高股本回報率是優質業務的好兆頭。因此,你可能希望看到這份免費收藏的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論